{"schema_version":"1","generated_at":"2026-11-22T19:52:49.923Z","data_as_of":null,"url":"https://www.findmykol.com/kol/anita-kiehl","json_url":"https://www.findmykol.com/kol/anita-kiehl/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"anita-kiehl","name":"Anita Kiehl","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"institution":"New York State Department of Health","institution_url":"https://www.findmykol.com/institution/new-york-state-department-of-health","city":"Albany","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Anita Kiehl is an Infectious Disease physician affiliated with New York State Department of Health. OpenAlex indexes 8 publications with 273 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":8,"cited_by_count":273,"h_index":6,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":17,"program_years":{"first":2021,"last":null},"rows_total":48,"shown":3,"withheld":45,"rows":[{"payer":"Astellas Pharma US Inc","program_year":2025,"amount_usd":173.86,"payment_count":5},{"payer":"ViiV Healthcare Company","program_year":2025,"amount_usd":95.58,"payment_count":4},{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":94.85,"payment_count":4}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Anti-infectives","share_pct":100,"classes_total":7,"classes":[{"class":"Tetracycline-class Drug","setting":"prescribed","share_pct":22.7,"drugs":[{"name":"Doxycycline Hyclate","share_pct":100}],"max_beneficiaries":null},{"class":"Cephalosporin Antibacterial","setting":"prescribed","share_pct":21.9,"drugs":[{"name":"Ceftriaxone","share_pct":50},{"name":"Cefuroxime","share_pct":50}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":8.9,"facility_pct":91.1},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":1995,"last":1995},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"F32AI008704","title":"EBV POLYMERASE AND ITS ACCESSORY PROTEIN","fiscal_year":1995,"organization":"WADSWORTH CENTER","source_url":"https://reporter.nih.gov/quickSearch/F32AI008704"}],"source":"grants"},"publications":{"total":8,"shown":5,"withheld":3,"matched_by":"OpenAlex author record","recent":[{"title":"Multiple 5′ ends of human cytomegalovirus UL57 transcripts identify a complex, cycloheximide-resistant promoter region that activates oriLyt","year":2003,"journal":"Virology","source_url":"https://doi.org/10.1016/s0042-6822(03)00438-0","status":"verified"},{"title":"Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication","year":1996,"journal":"Journal of Virology","source_url":"https://doi.org/10.1128/jvi.70.8.5131-5142.1996","status":"verified"},{"title":"These include:","year":1996,"status":"verified"},{"title":"Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function","year":1995,"journal":"Journal of Virology","source_url":"https://doi.org/10.1128/jvi.69.3.1669-1677.1995","status":"verified"},{"title":"Natural infections with Borrelia spirochetes in two dogs from Florida","year":1994,"journal":"Journal of Clinical Microbiology","source_url":"https://doi.org/10.1128/jcm.32.2.352-357.1994","status":"verified"}],"source":"works"},"similar":[{"name":"Gang Liu","slug":"gang-liu","institution":"New York State Department of Health","url":"https://www.findmykol.com/kol/gang-liu","json_url":"https://www.findmykol.com/kol/gang-liu/profile.json"},{"name":"Debra Blog","slug":"debra-blog","institution":"New York State Department of Health","specialty":"Public Health & General Preventive Medicine","url":"https://www.findmykol.com/kol/debra-blog","json_url":"https://www.findmykol.com/kol/debra-blog/profile.json"},{"name":"Charles Gonzalez","slug":"charles-gonzalez","institution":"New York State Department of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/charles-gonzalez","json_url":"https://www.findmykol.com/kol/charles-gonzalez/profile.json"},{"name":"Foster Gesten","slug":"foster-gesten","institution":"New York State Department of Health","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/foster-gesten","json_url":"https://www.findmykol.com/kol/foster-gesten/profile.json"},{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":45,"publications":3}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}